741 related articles for article (PubMed ID: 16308159)
21. Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Kuhn C; Jeschke U; Briese V; Friese K
Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):101-8. PubMed ID: 15596282
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
[TBL] [Abstract][Full Text] [Related]
23. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
24. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
[TBL] [Abstract][Full Text] [Related]
25. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
26. Distribution of estrogen receptors in various cell types of normal, hyperplastic, and neoplastic human endometrial tissues.
Bergeron C; Ferenczy A; Shyamala G
Lab Invest; 1988 Mar; 58(3):338-45. PubMed ID: 3347010
[TBL] [Abstract][Full Text] [Related]
27. Significance of CD44v6 expression in gynecologic malignancies.
Hong SC; Song JY; Lee JK; Lee NW; Kim SH; Yeom BW; Lee KW
J Obstet Gynaecol Res; 2006 Aug; 32(4):379-86. PubMed ID: 16882263
[TBL] [Abstract][Full Text] [Related]
28. Tenascin expression in the human endometrium and in endometrial adenocarcinomas.
Vollmer G; Siegal GP; Chiquet-Ehrismann R; Lightner VA; Arnholdt H; Knuppen R
Lab Invest; 1990 Jun; 62(6):725-30. PubMed ID: 1694256
[TBL] [Abstract][Full Text] [Related]
29. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
[TBL] [Abstract][Full Text] [Related]
30. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
31. CD44 expression in normal, hyperplastic, and malignant endometrium.
Saegusa M; Hashimura M; Okayasu I
J Pathol; 1998 Mar; 184(3):297-306. PubMed ID: 9614383
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
Pilka R; Norata GD; Domanski H; Andersson C; Hansson S; Eriksson P; Casslén B
Gynecol Oncol; 2004 Sep; 94(3):661-70. PubMed ID: 15350356
[TBL] [Abstract][Full Text] [Related]
33. Total sialic acid content in endometrial cancer tissue in relation to normal and hyperplastic human endometrium.
Paszkowska A; Cybulski M; Semczuk A; Postawski K; Berbe H
Cancer Detect Prev; 2000; 24(5):459-63. PubMed ID: 11129988
[TBL] [Abstract][Full Text] [Related]
34. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
35. Galectin-3 expression in normal, hyperplastic, and neoplastic endometrial tissues.
Brustmann H; Riss D; Naudé S
Pathol Res Pract; 2003; 199(3):151-8. PubMed ID: 12812316
[TBL] [Abstract][Full Text] [Related]
36. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
37. Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Gynecol Oncol; 2004 Apr; 93(1):92-7. PubMed ID: 15047219
[TBL] [Abstract][Full Text] [Related]
38. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
39. [Expression of glucose transporter-1 in endometrial hyperplasia and well-differentiated endometrioid adenocarcinoma].
Liu AJ; Hou N; Chen LZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):398-400. PubMed ID: 12940086
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia.
Nieminen TT; Gylling A; Abdel-Rahman WM; Nuorva K; Aarnio M; Renkonen-Sinisalo L; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Clin Cancer Res; 2009 Sep; 15(18):5772-83. PubMed ID: 19723644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
